Department of Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.
Department of Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.
Epidemiol Health. 2018;40:e2018053. doi: 10.4178/epih.e2018053. Epub 2018 Nov 7.
Little is known about the life expectancy of individuals with human immunodeficiency virus (HIV) in Iran. This study therefore aimed to estimate the life expectancy of HIV-positive patients in Iran.
In this retrospective cohort study, we extracted data from the Center for Disease Control and Prevention of the Ministry of Health and Medical Education and the Death Registration System. We included patients aged 20 years and older who had a specified date of diagnosis. We estimated life expectancy and its 95% confidence intervals (CIs) using Chiang's methodology.
The overall life expectancy at the national level was 23.1 years (95% CI, 22.6 to 23.5). Life expectancy was 21.6 years (95% CI, 21.1 to 22.0) for men and 32.7 years (95% CI, 31.4 to 34.0) for women. The life expectancy of patients who did or did not receive antiretroviral therapy (ART) was 37.0 years (95% CI, 36.2 to 37.8) and 15.5 years (95% CI, 15.1 to 15.9), respectively. The life expectancy of patients with or without tuberculosis (TB) was 21.6 years (95% CI, 20.4 to 22.9) and 36.5 years (95% CI, 35.7 to 37.4), respectively.
The life expectancy of Iranian HIV-positive patients was found to be very low. To improve their longevity, improvements in ART coverage and the control and treatment of TB are advised.
关于伊朗艾滋病毒（HIV）感染者的预期寿命知之甚少。因此，本研究旨在估计伊朗 HIV 阳性患者的预期寿命。
在这项回顾性队列研究中，我们从卫生部和医疗教育部疾病控制中心和死亡登记系统中提取数据。我们纳入了年龄在 20 岁及以上、有特定诊断日期的患者。我们使用 Chiang 的方法估计了预期寿命及其 95%置信区间（CI）。
全国总体预期寿命为 23.1 年（95%CI，22.6 至 23.5）。男性预期寿命为 21.6 年（95%CI，21.1 至 22.0），女性为 32.7 年（95%CI，31.4 至 34.0）。接受或未接受抗逆转录病毒治疗（ART）的患者的预期寿命分别为 37.0 年（95%CI，36.2 至 37.8）和 15.5 年（95%CI，15.1 至 15.9）。患有或未患有结核病（TB）的患者的预期寿命分别为 21.6 年（95%CI，20.4 至 22.9）和 36.5 年（95%CI，35.7 至 37.4）。
伊朗 HIV 阳性患者的预期寿命非常低。为了提高他们的寿命，建议提高 ART 覆盖率以及控制和治疗结核病。
